Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Melanoma Research|June 21, 2022
Exceptional response to combination ipilimumab and nivolumab in metastatic uveal melanoma: Insights from genomic analysisIrene S Yu, Kathleen Wee, Laura Williamson, et al.
Molecular Therapy Oncolytics|May 6, 2020
A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell ToxicityJoanne A Hammill, Jacek M Kwiecien, Anna Dvorkin-Gheva, et al.
Frontiers in Immunology|February 6, 2024
Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophagesSarah Nersesian, Riley J Arseneau, Jorge P Mejia, et al.
Molecular and Cellular Biology|October 29, 2004
FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanismSilvia Fernández de Mattos, Abdelkader Essafi, Inês Soeiro, et al.
Cancer Immunology, Immunotherapy : CII|December 2, 2021
MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cuesTony Yao, Patrick T Rudak, Céline M Laumont, et al.
Therapeutic Advances in Medical Oncology|May 12, 2025
Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib studyGlenwood Goss, Tudor Ciuleanu, Rodryg Ramlau, et al.
Oncotarget|June 18, 2020
Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancerAnders Handrup Kverneland, Magnus Pedersen, Marie Christine Wulff Westergaard, et al.
Cancer Research Communications|March 13, 2023
Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and SignalingIsrael Matos, Maunish Barvalia, Manreet K Chehal, et al.
The Journal of Pathology|April 14, 2025
Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinomaSpencer D Martin, Shelby Thornton, Christine Chow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2015
Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T CellsJulie S Nielsen, Colin G Sedgwick, Aniqa Shahid, et al.
Pageof 14